4523

Eisai
4523

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥1.30T
EV
¥1.28T
Shares Outstanding
281.89M
Beta
-0.18

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
¥4592.31
P/E 2026E
29.06x
P/Revenue 2026E
1.63x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Eisai Co., Ltd.

gainify
4523

Eisai Co., Ltd.

4523

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cance...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Naito, Haruo

Employees

10,917

IPO Date

2000-01-04

Headquarters

4-6-10, Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.